With a market cap of has a large market cap size. Illumina Inc. (NASDAQ: ILMN) has been on the stock market since its IPO date on the 7/28/2000. Illumina Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Illumina Inc., is 1052.1, and so far today it has a volume of 1080400. Performance year to date since the 7/28/2000 is -5.06%.
To help you determine whether Illumina Inc. is undervalued the following values will help you decide. P/E is 62.64 and forward P/E is 44.61. PEG perhaps more useful shows that Illumina Inc. has a value for PEG of 3.92. P/S ratio is 11.56 and the P/B ratio is 13.01. The P/Cash and P/Free cash flow is 18.77 and 54.38 respectively.
At the current price Illumina Inc. is trading at, 182.23 (0.31% today), Illumina Inc. has a dividend yield of *TBA, and this is covered by a payout ratio of 0.00%. Earnings per share (EPS) is 2.91, and this is looking to grow in the next year to 15.72% after growing 30.50% this past year. EPS growth quarter over quarter is 18.60%, and 11.30% for sales growth quarter over quarter.
The number of shares outstanding is 146.78, and the number of shares float is 145.1. The senior management bring insider ownership to 1.00%, and institutional ownership is at 97.70%. The float short is 3.47%, with the short ratio at a value of 4.79. Management has seen a return on assets of 11.40%, and also a return on investment of 16.60%.
The ability for Illumina Inc., to deal with debt, means it current ratio is 3.7, and quick ratio is 3.1. Long term debt/equity is 0.5 and total debt/equity is 0.5. In terms of margins, Illumina Inc. has a gross margin of 70.00%, with its operating margin at 24.60%, and Illumina Inc. has a profit margin of 18.70%.
The 52 week high is -7.25%, with 43.38% being its 52 week low. The 20 day simple moving average is 7.30% and the 200 day simple moving average is 15.62%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.